Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment

NCT03040778 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03040778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment
Lead sponsor
University of Washington
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 1, 2018
Completion date
June 30, 2026
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, bisphosphonate-related osteonecrosis of the jaw, medication-related osteonecrosis of the jaw